Nomura

Nomura’s Lorenz Altenburg is set to join CaixaBank in January, where he will head the firm’s fixed income syndicate in its recently established Corporate & Institutional Banking (CIB) division.

Cooper, the French pharmaceuticals distributor, has priced the term loan ‘B’ for its acquisition by Charterhouse at 475bp over Euribor, with an original issue discount of 99.5, the wide end of initial talk that began at 450bp.

Santander UK has beaten a path that could be well trodden by European banks in the next two years, printing a holdco senior unsecured deal in the Tokyo Pro-Bond market as it looks to broaden its investor base for issuing loss absorbing debt.

Carlyle Group has sold its stake in RAC, the UK roadside recovery firm, to CVC Capital Partners in a deal that values the business at £2.2bn, including debt.

BPCE issued final guidance on Thursday for its latest multi-tranche Samurai sale, giving investors plenty of choice with two senior and three subordinated tranches.

The Australian dollar market, a popular funding pool for SSAs, will require a pragmatic approach in terms of price expectations next year, said senior SSA bankers.

Drug manufacturer Alkem Laboratories has set the price range for its Rp13.5bn ($202m) IPO in India, with the offering set to launch on December 8.

Albaraka Turk Katilim Bankasi (Albaraka Turk) priced Turkey’s first Basel III compliant tier two sukuk deal in line with guidance on Monday.

Coopération Pharmaceutique Française, the French pharmaceuticals distributor known as Cooper, has bank meetings scheduled on Wednesday for more than €350m of new debt for its leveraged buyout by Charterhouse.

Logan Property Holdings Co raised HK$1.55bn ($200m) from a top-up placement on November 25, which was well received despite investors’ lack of familiarity with the company.

Swedbank bucked a trend of issuers turning to covered bonds for funding on Thursday when it launched a five year fixed rate senior deal.

Logan Property Holdings Co raised HK$1.55bn ($200m) from a top-up placement on November 25, pulling off a successful trade despite the huge chunk of shares on sale and investors’ lack of familiarity with the company.